Influence of Recombinant Human Erythropoietin Therapy on in vivo Chemotaxis and in vitro Phagocytosis of Polymorphonuclear Cells of Hemodialysis Patients

Blood Purification

Volumn 14, Issue 2, 1996, Pages 157-164

  Sperschneider, H ^a   Neumann, K ^a   Ruffert, K ^a   Stein, G ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Chemotactic activity; Hemodialysis patients; Phagocytic activity; Polymorphonuclear leukocyte function; Recombinant human erythropoietin

Indexed keywords

ANTIANEMIC AGENT; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; CHEMOTAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROPOIESIS; FEMALE; HEMATOCRIT; HEMODIALYSIS; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; LYMPHOCYTE; MALE; MONOCYTE; NEUTROPHIL; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANEMIA; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; COMBINED MODALITY THERAPY; ERYTHROPOIETIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRON; KIDNEY FAILURE, CHRONIC; LEUKOCYTE COUNT; LEUKOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PHAGOCYTOSIS; RECOMBINANT PROTEINS; RENAL DIALYSIS; SKIN WINDOW TECHNIQUE;

EID: 0029892197     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000170257     Document Type: Article

References (28)

1. Ganser A. Völkers B. Scigalla P. Holzer D: Effect of human recombinant erythropoietin on human progenitor cells in vitro. Klin Wochensehr 1988;66:236-240.
2. Koenig JM. Christensen RD: Effect of erythropoietin on granulocyto-poiesis: In vitro and in vivo studies in weanling rats. Pediatr Res 1990; 27:583-587.
3. Mayani H, Guilbert LI, Janowska-Wieezorek A: Modulation of eryth-ropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures. Exp Hematol 1990:18:174-179.
4. Boclaert JR, Cantinicaux BF, Hari-ga CF, Fondu PG: Recombinant erythropoietin reverses polymorphonuclear granulocyte dysfunction in iron-overloaded dialysis patients. Nephrol Dial Transplant 1990:5: 504-507.
5. Peters NP. Holland MD. Scnn HJ, Romberg W, Banerjee T: Corticosteroid administration and localized leucocyte mobilization in men. N Engl J Med 1972:286:342-345.
6. Scnn HJ. Holland DF. Banerjee T: Kinetic and comparative studies on localized leucozyte mobilisation in normal man. J Lab Clin Med 1969: 74:742-756.
7. Ruffert K, Jorke D, Krumbholz B, Otto K: Stimulicrte Granulozyten-mobilisation bei Normalpersonen und bei Patienten mit Granulozyto-penie. Folia Haematol (Leipz) 1979; 106:558-576.
8. Suss J, Bakacs T, Balazs C: The phagocytosis capacity assay: A new radiometric phagocytosis test for clinical use. J Immunol Methods 1982:53:69-74.
9. Petri I, Egerer R, Stelzner A, Siiss J, Schiitz H: Development of mathematical models for an in vitro-phagocytosis test system. Zentralbl Bakteriol Mikrobiol Hyg [A] 1987; 267:217-227.
10. De Haan G, Loeffler M, Nijhof W: The mutual inhibition of erythro-poiesis and granulopoiesis during G-CSF and erythropoietin administration (abstract). Exp Hematol 1992; 20:772.
11. Liechty KW. Koenig JM. Olds RK. Schibler KR. Christensen RD: Erythropoietin administration to neonatal rats results in decreased neutrophil production (abstract 852). Pediatr Res 1991;29:145A.
12. Fuchs A: Einflussvon Erythropoelin (RHEPO) auf die Hematopocse bcim Kaninchen: thesis. Giessen, 1992.
13. Wright DG, Germaine ST, Jacobson RJ: Evidence that recombinant human erythropoietin (RHEPO) may exacerbate neutropenia in myclo-suppressed cancer patients (abstract). Clin Res 1991:39:171.
14. Christensen RD, Koenig JM, Viskochil D, Rothstein G: Down-modulation of neutrophil production by erythropoietin in human hematopoietic clones. Blood 1989:74:817-822.
15. Kling PJ. Widness JA, Peters C. De Alarcon P, Guillery E: Recombinant human erythropoietin (rh-EPO) kinetics in an infant with renal failure (abstract). Clin Res 1991:39:702.
16. Peterson V, Rundus C, Reiaohl P, Golosow L, Tsujiy J: Erythropoietin (EPO) stimulates both crythroid and myeloid proliferation following burn injury (abstract). Blood 1990: 76(suppl 1): 160.
17. Hernandez E, Oliet A, Llanos M, Gallar P: Influence of erythropoietin treatment on lymphocyte subsets (abstract). Paris. European Dialysis and Transplant Association. 1992. p 191.
18. Stein G, Sperschneider H, Thieler H, Dutz W, Hans S, Voigt D, Marx M, Engclmann J, Scigalla P: Verglei-chendc Studie des Einsatzes von Erythropoelin (i.v. vs. s.c.) zur Kor-rektur der renalen Atlantic; in Koch KM. Rosenthal J, Flcisch H. Scigalla P (eds): Nephrologic-Ncue Aspck-te der Therapie der Nierenkranken. Heidelberg, Springer. 1992. vol 2. pp 32-39.
19. Berglund B. Ekblom B: ElTcct of recombinant human erythropoietin treatment on blood pressure and some hematological parameters in healthy men. J Intern Med 1991; 229:125-130.
20. Asaka M, Iida H, Izumio K, Sasavama S: Depressed natural killer cell activity in uremia. Nephron 1988; 49:191-195.
21. Kottke M. Seifert D. Suss J. Winnc-fcld K. Stein G: Untersuchungen zum Einflusseincrchronischen Nie-rcninsulfizicnz und von Aluminium auf die Phagozytoscaktivitat von Leukozyten. Nieren Hochdruek-krankh 1993:22:66-72.
22. Bartunkova J, Fucikova T, Sulkova S, Marenkova H:The effect of erythropoietin on lymphocyte and granulocyte functions in dialysed patients. CasLekCesk 1989;128:1332-1335.
23. Veys N. Vanholdcr R. Ringio S: Correction of deficient phagocytosis during erythropoietin treatment in maintenance hemodialysis patients. Am J Kidney Dis 1992; 19:358-363.
24. Lewis SI, Van Epps DE, Chenoweth DE: Alterations in chemotactic factor induced responses of neutro-philes and monocytes from chronic dialysis patients. Clin Nephrol 1988:30:63-72.
25. Miller ME: Pathology of chemotaxis and random migration. Semin Hematol 1975; 12:59-81.
26. Lewis SL. Van Epps DE: Neutrophils and monocytes alterations in chronic dialysis patients. Am J Kidney Dis 1987:9:381-395.
27. Waterlot Y. Cantinieaux B. Hariga-Miiller S. De-Maertelaere-Laurent E. Vanherweghem JL. Fondu P: Impaired phagocytotic activity of neutrophils in patients receiving hemodialysis. The critical role of iron overload. Br Med J 1985:291:501-504.
28. Repp R, Valerius Th, Sendler A, Gramatzki M, Iro H, Kalden JR. Platzer F.: Neutrophils express the high affinity receptor for IgG (FCyRl. CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor. Blood 1991;78:885-889.